In a two-phased process, an ad hoc committee will undertake the second phase to conduct the assessment/evaluation of HIV/AIDS programs implemented under the Tom Lantos and Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 and issue a report to the U.S. Congress on the committee's findings and recommendations in 2012. In conducting the evaluation, the committee will follow the approach developed in the first phase, described in the IOM/NRC report, Strategic Approach to the Evaluation of Programs Implemented Under the Tom Lantos and Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008.

The congressionally-mandated tasks are an assessment of the performance of United States-assisted global HIV/AIDS programs and an evaluation of the impact on health of prevention, treatment, and care efforts that are supported by United States funding, including multilateral and bilateral programs involving joint operations.¹ Further, Congress asked that the IOM study include the following as part of its evaluation:

(i)

an assessment of progress toward prevention, treatment, and care targets;

(ii)

an assessment of the effects on health systems, including on the financing and management of health systems and the quality of service delivery and staffing;

(iii)

an assessment of efforts to address gender-specific aspects of HIV/AIDS, including gender-related constraints to accessing services and addressing underlying social and economic vulnerabilities of women and men;

(iv)

an evaluation of the impact of treatment and care programs on 5-year survival rates, drug adherence, and the emergence of drug resistance;

(v)

an evaluation of the impact of prevention programs on HIV incidence in relevant population groups;

(vi)

an evaluation of the impact on child health and welfare of interventions authorized under the Act on behalf of orphans and vulnerable children;

(vii)

an evaluation of the impact of programs and activities authorized in the Act on child mortality; and

(viii)

recommendations for improving the HIV/AIDS programs implemented under the U.S. Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008.

Sponsor: U.S. Department of State.